Phenylbutazone

规格

50-33-9CAS 号

200-029-0EC 号

4-butyl-1,2-diphenylpyrazolidine-3,5-dioneIUPAC 名称

C19H20N2O2化学式

308.4 g/mol分子量

phenylbutazone; 50-33-9; 4-Butyl-1,2-diphenylpyrazolidine-3,5-dione; Butapirazol; Butazolidin; Butadion; Flexazone; Azolid; Butacote; Butazolidine; Ecobutazone; Fenibutazona; Fenilbutazona; Fenylbutazon; Intrabutazone; Artrizin; Butadiona; Diphebuzol; Fenibutol; Intrazone; Phebuzine; Butoz; Buzon; Diphenylbutazone; Equipalazone; Bute; Phenylbutazonum; Alkabutazona; Alqoverin; Anuspiramin; Arthrizon; Artrizone; Bunetzone; Butacompren; Butagesic; Butalgina; Butalidon; Butapirazole; Butarecbon; Butartril; Butartrina; Butidiona; Butylpyrin; Buvetzone; Chembutazone; Digibutina; Diossidone; Eributazone; Fenibutal; Fenibutasan; Fenilbutina; Fenilbutine; Fenilidina; Mephabutazon; Mephabutazone; Phenbutazol; Phenopyrine; Phenyzone; Praecirheumin; Pyrabutol; Alindor; Anerval; Anpuzone; Artropan; Azobutyl; Benzone; Betazed; Bizolin; Butaluy; Butazina; Butazona; Elmedal; Febuzina; Fenartil; Fenotone; Nadazone; Reumazin; Reumuzol; Robizone; Zolaphen; Busone; Butone; Diozol; Kadol; Lingel; Reudo; Reudox; Uzone; 4-Butyl-1,2-diphenyl-3,5-pyrazolidinedione; Butiwas-Simple; Equi bute; Exrheudon N; Robizone-V; Shigrodin; Tevcodyne; Ia-But; Pirarreumol B; 4-Butyl-1,2-diphenyl-3,5-dioxopyrazolidine; Bizolin 200; Phenylbutazon; Butatron; Butadionum; Schemergen; Phenyzene; Tencodyne; Ticinil; Ambene; Mepha-Butazon; 3,5-Pyrazolidinedione, 4-butyl-1,2-diphenyl-; esteve; Fenilbutazone; 4-BUTYL-1,2-DIPHENYL-PYRAZOLIDINE-3,5-DIONE; R-3-ZON; VAC-10; 3,5-Dioxo-1,2-diphenyl-4-N-butylpyrazolidine; 4-n-Butyl-1,2-diphenyl-3,5-pyrazolidinedione; DA-192; DTXSID9021136; 1,2-Diphenyl-4-butyl-3,5-pyrazolidinedione; G 13,871; 1,2-Diphenyl-3,5-dioxo-4-butylpyrazolidine; 1,2-Diphenyl-4-butyl-3,5-dioxopyrazolidine; NCI-C56531; 3,5-Dioxe-4 buty-1, diphenyl-pyrazolidine; GN5P7K3T8S; NSC-25134; G 13871; CHEBI:48574; DTXCID601136; G-13871; Pributazone; Superiorbute; Butaject; Butequine; Equiphar; VetriBute; Butatron Gel; Pro-Bute; EquiBute Injection; Bizolin 1-G; Butazolidin Granules; Tevcodyne Injectable; Equizone 100; EQUIZONE; PHENYLBUTE; Phenylbutazone Boluses; EQUI-PHAR; Bizolin Injection 20%; Phen-Buta Vet Injection; Phen-Buta-Vet Injection; RefChem:929062; Robizone Injectable 20%; EquiBute Tablets 100 mg; Butazolidin Injectable 20%; Phenylbutazone 20% Injection; EQUIZONE 50/100; Bizolin-100, Bizolin-200; M01AA01; M02AA01; Phenylbutazone Tablets, USP 1 gram; Butazolidin Bolus, Butazolidin Tablets; Phen-Buta-Vet Tablets, Phenylbutazone S/A; Phen-Buta Vet Tablets, Phenylbutazone Tablets (Horses); Butazolidin, Butazolidin Paste, Bute, Phenylbute Paste, Phenylzone Paste; Phenylbutazone Tablets, USP 100 mg, Phenylbutazone Tablets, USP 200 mg; 200-029-0; Butazone; Butapyrazole; Scanbutazone; Intalbut; Ipsoflame; Malgesic; Merizone; Nadozone; Novophenyl; Phebuzin; Phenylbutaz; Pyrazolidin; Rectofasa; Reumasyl; Reumazol; Reupolar; Rubatone; Antadol; Reumune; Neo-zoline; Phenyl-Mobuzon; Robizon-V; Butaphen; Azdid; Buta phen; Schemergin; Wescozone; Tazone; Phen-Buta-Vet; Therazone; Todalgil; Zolidinum; Tetnor; B.t.z.; Usaf ge-15; A 7514; 3,5-Dioxo-1,2-diphenyl-4-n-butyl-pyrazolidin; Fenilbutazon; MFCD00005500; MLS000069424; NCI-C55414; s1654; 'Esteve'; NCGC00015846-10; NCGC00015846-11; SMR000059073; Fenilbutazone [DCIT]; Phenylbutazon [German]; P1Z; Fenilbutazona [INN-Spanish]; Phenylbutazonum [INN-Latin]; Phenyl butazone; CAS-50-33-9; CCRIS 2374; component of Azolid-A; HSDB 3159; 4-butyl-1,2-diphenyl-1,2-diazolidine-3,5-dione; SR-01000000004; AZOLID (TN); EINECS 200-029-0; NSC 25134; UNII-GN5P7K3T8S; BRN 0290080; Alkazone; Phenogel; 50-33-9 (free form); Butapirazole;; Fenylbutazon;; Phenbutazone;; Butazolidin;; Butalidon;; Butacote;; Butadion;; Diphenylbutazone;; Phen-Buta; Pirarreumol 'B'; Phenylbutazone CRS; Phenylbutazone [USP:INN:BAN:JAN]; 1,5-dioxopyrazolidine; Spectrum_001079; 4-Butyl-1,5-dione; Opera_ID_888; Spectrum2_001282; Spectrum3_000675; Spectrum4_000477; Spectrum5_001335; Lopac-P-8386; Phenylbutazone (Standard); P1686; Epitope ID:124940; P 8386; PHENYLBUTAZONE [MI]; SCHEMBL3632; PHENYLBUTAZONE [INN]; PHENYLBUTAZONE [JAN]; Lopac0_000993; Oprea1_416494; BSPBio_002369; KBioGR_000954; KBioSS_001559; PHENYLBUTAZONE [HSDB]; PHENYLBUTAZONE [IARC]; MLS001148412; MLS002152929; DivK1c_000331; PHENYLBUTAZONE [VANDF]; SPECTRUM1500482; SPBio_001283; PHENYLBUTAZONE [MART.]; 1,5-dioxo-4-butylpyrazolidine; 3, 4-butyl-1,2-diphenyl-; 4-Butyl-1,5-dioxopyrazolidine; 4-Butyl-1,5-pyrazolidinedione; GTPL7270; orb1308640; orb3140016; PHENYLBUTAZONE [USP-RS]; PHENYLBUTAZONE [WHO-DD]; 1,3-dioxo-4-N-butylpyrazoline; HMS501A13; HY-B0230R; KBio1_000331; KBio2_001559; KBio2_004127; KBio2_006695; KBio3_001589; MSK7138; NINDS_000331; Phenylbutazone (JP18/USP/INN); HMS1920H06; HMS2090H17; HMS2091P08; HMS2233B13; HMS3263G07; HMS3369P16; HMS3649M17; HMS3651G15; HMS3715E21; HMS3884C06; HMS5079D08; Pharmakon1600-01500482; Phenylbutazone, analytical standard; component of Azolid-A (Salt/Mix); Phenylbutazone - Bio-X trade mark; PHENYLBUTAZONE [GREEN BOOK]; HY-B0230; NSC25134; 3,2-diphenyl-4-N-butylpyrazolidine; PHENYLBUTAZONE [ORANGE BOOK]; Tox21_110242; Tox21_110243; Tox21_201809; Tox21_302763; Tox21_500993; 3,2-diphenyl-4-N-butyl-pyrazolidin; AC-683; CCG-39220; EBC-03849; NSC757272; PHENYLBUTAZONE [EP MONOGRAPH]; SBB012526; STK388348; PHENYLBUTAZONE [USP MONOGRAPH]; AKOS001592731; Phenylbutazone (Butazolidin, Butatron); Tox21_110242_1; DB00812; FP26944; KS-5127; LP00993; NSC-757272; SDCCGSBI-0050966.P005; WLN: T5VNNV EHJ BR& CR& E4; IDI1_000331; NCGC00015846-01; NCGC00015846-02; NCGC00015846-03; NCGC00015846-04; NCGC00015846-05; NCGC00015846-06; NCGC00015846-07; NCGC00015846-08; NCGC00015846-09; NCGC00015846-12; NCGC00015846-13; NCGC00015846-15; NCGC00015846-27; NCGC00023855-03; NCGC00023855-04; NCGC00023855-05; NCGC00023855-06; NCGC00023855-07; NCGC00023855-08; NCGC00181112-01; NCGC00256449-01; NCGC00259358-01; NCGC00261678-01; Phenylbutazone; Suxibuzone EP Impurity A; 4297-92-1; BP166190; ST066897; SBI-0050966.P004; DB-051755; SUXIBUZONE IMPURITY A [EP IMPURITY]; EU-0100993; NS00000675; P2810; SW199456-2; UNM000001255503; 1,2-diphenyl-3,5-dioxo-4-butyl-pyrazolidine; Phenylbutazone, SAJ special grade, >=99.0%; 1,2-diphenyl-3,5-dioxo-4-n-butylpyrazolidine; C07440; D00510; EN300-126733; 1,2-diphenyl-3,5-dioxo-4-n-butyl-pyrazolidine; AB00052071-15; AB00052071-16; AB00052071_17; AB00052071_18; AG-205/04675049; F358148; Q421342; SR-01000000004-2; SR-01000000004-4; SR-01000000004-5; SR-01000000004-9; BRD-K10843433-001-12-8; BRD-K10843433-001-20-1; BRD-K10843433-001-21-9; BRD-K10843433-001-22-7; BRD-K10843433-001-23-5; SR-01000000004-13; Z57355370; Phenylbutazone, TraceCERT(R), certified reference material; Phenylbutazone Working Standard (Secondary Reference Standard); Phenylbutazone, European Pharmacopoeia (EP) Reference Standard; Phenylbutazone, United States Pharmacopeia (USP) Reference Standard; InChI=1/C19H20N2O2/c1-2-3-14-17-18(22)20(15-10-6-4-7-11-15)21(19(17)23)16-12-8-5-9-13-16/h4-13,17H,2-3,14H2,1H同义词